I am a
Home I AM A Search Login

Papers of the Week

2020 Mar 31

J Clin Med



The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study.


Verster JC, Dahl TA, Scholey A, Iversen JM
J Clin Med. 2020 Mar 31; 9(4).
PMID: 32244274.


Despite a clear market need and many hangover products available, currently there is no hangover treatment that is supported by substantial scientific evidence demonstrating its efficacy and safety. A pilot study was conducted to investigate the effects of a potential new hangover treatment, SJP-001, and its constituents (220 mg naproxen and 60 mg fexofenadine) on hangover severity.